• Thyroid/parotid tumor surgery candidates

• Cervical cystic lesions (e.g., lymphatic malformations)

• Head & neck cancer patients needing neck dissection

• All ages seeking a scarless approach

Our hospital has introduced the da Vinci robotic surgical system as a key platform for minimally invasive and precision surgery across multiple specialties. The Department of Otolaryngology leverages this system to develop “scarless neck” procedures for selected cases involving benign or malignant thyroid, parotid, and other neck tumors/lesions that require meticulous dissection and functional preservation. By using transhairline or retroauricular concealed incisions together with a magnified three-dimensional view and stable instrument control, the team enhances identification and protection of critical neurovascular structures, reduces visible cervical scarring and the associated psychological burden, while maintaining surgical safety, oncologic completeness, and postoperative quality of life. This service covers patients from pediatric to adult populations and provides individualized care centered on both cosmetic and functional needs.

• Transhairline or retroauricular approach with the da Vinci system: concealed incision for improved cosmetic outcomes

• Magnified 3D precision surgery: enhanced identification and protection of critical neurovascular structures

• All-age platform (pediatric to adult; Taiwan’s only): comprehensive scarless-neck surgical service

• Hybrid OR integration (intervention + resection): streamlined management for complex, high-risk cases

• As of May 2025, our team has performed over 700 da Vinci robotic surgeries.

• From 2014 to May 2025, a total of 51 “scarless neck” procedures have been performed.

• Pediatric patients with cervical lymphangioma ranged in age from 3 months to 11 years.

• Surgical success rate: 100% (2022–2024)

• 6-month postoperative recurrence rate: 0% (2022–2024)

• Conversion to open surgery or intraoperative incision extension rate: 0% (2022–2024)

• 30-day postoperative complication rate: 0% (2022–2024)

• 30-day postoperative infection rate: 0% (2022–2024)

• Postoperative nerve injury rate: 0% (2022–2024)

• 48-hour postoperative mortality rate: 0% (2022–2024)

• Preoperative visit satisfaction: 97.4%–100% (2023–2024)

• Postoperative follow-up satisfaction: 98%–100% (2023–2024)

• Department of Otolaryngology complaints/adverse event reports: 0.06% (2022-2024)

• 16 publications on da Vinci surgery (including 9 SCI-indexed papers)

• Invited speaker at 12 national/international lectures & symposia (2022–2025)

• Taiwan’s only training platfom for Asia TR200/TR300 cum ENT da Vinci Surgery Observership Center

• Taiwan’s first center to concurrently develop robotic neck surgery programs for both pediatric and adult patients.

• Scarless minimally invasive surgery balances aesthetics and function, reducing scar-related anxiety.

• Magnified 3D precision surgery lowers complication rates and accelerates recovery.

• Established SOPs and simulation-based training modules to implement standardized care.

• Hybrid OR integration of intervention and resection enhances management of complex, high-risk cases.

• TR200/TR300 training and observership output strengthens regional and international exchange.

• Improved operative efficiency and resource utilization supporting healthcare sustainability.